[Federal Register Volume 83, Number 111 (Friday, June 8, 2018)]
[Notices]
[Pages 26687-26688]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12373]
[[Page 26687]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-18-0969; Docket No. CDC-2018-0044]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Monitoring Changes in Attitudes
and Practices among Family Planning Providers and Clinics. This project
seeks to obtain information on changes in attitudes and practices among
family planning providers and clinics in the United States related to
recommendations from national contraception guidelines.
DATES: CDC must receive written comments on or before August 7, 2018.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2018-
0044 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Leroy A. Richardson, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Monitoring Changes in Attitudes and Practices among Family Planning
Providers and Clinics (OMB No. 0920-0969, exp. 5/31/2014)--
Reinstatement with Change--National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The Division of Reproductive Health (DRH) at the Centers for
Disease Control and Prevention (CDC) and the HHS Office of Population
Affairs (OPA) develop and disseminate guidance to improve the use of
contraception and the delivery of quality family planning services. The
U.S. Medical Eligibility Criteria for Contraceptive Use (US MEC), the
first national guidance on family planning containing evidence-based
recommendations for the safe use of contraceptive methods for women and
men with specific characteristics and medical conditions, was first
published by the CDC in June 2010. The US Selected Practice
Recommendations for Contraceptive Use (US SPR), which provides guidance
on how to use contraceptive methods safely and effectively once they
are deemed to be medically appropriate, was first published by the CDC
in June 2013. The US MEC and US SPR were updated after review of the
scientific evidence and consultation with national experts in family
planning; the revised US MEC and US SPR were published in August 2016.
Providing Quality Family Planning Services (QFP), which provides
evidence-informed recommendations to improve client care and service
delivery infrastructure to support the provision of quality family
planning services to women and men of reproductive age in the United
States, was published by CDC and OPA in April 2014. The US MEC, US SPR,
and QFP have been widely disseminated to health care providers and
other constituents via professional organizations, federal program
grantees, scientific and programmatic meetings, scientific manuscripts,
online resources, and other avenues.
To monitor changes in attitudes and practices regarding provision
of contraception among family planning providers and clinics, we
initiated a multi-phase assessment. In 2009-2010, CDC carried out the
first phase of the assessment, collecting information before the
release of the US MEC (OMB No. 0920-0008). In 2013-2014, CDC, in
collaboration with OPA, carried out the second phase of the assessment,
collecting information before the release of the US SPR and QFP (OMB
No. 0920-0969). These information collections provided useful knowledge
about attitudes and practices of family planning providers. CDC and OPA
used the findings to develop educational materials and opportunities
for health care providers.
In 2018, in collaboration with OPA, CDC plans to request a
reinstatement of OMB No. 0920-0969, `Monitoring Changes in Attitudes
and Practices among Family Planning Providers and Clinics' to carry out
the third phase of the assessment. As in the previous phases, the
information collection will allow CDC and OPA to improve family
planning-related practice by: (1) Understanding the current use of
contraception guidance in practice,
[[Page 26688]]
including awareness and use of the US MEC, US SPR and QFP; (2)
describing current attitudes and practices among family planning
providers and clinics related to recommendations included in the US
MEC, US SPR, and QFP and assessing changes from previous data
collections; and (3) identifying training needs in use of guidance and
family planning service delivery (e.g., provider tools, continuing
education modules).
As in previous phases of data collection, CDC plans to administer
surveys to private and public sector family planning providers and
clinic administrators in the United States. The design, methodology,
and analytic approach that CDC plans to implement are based on methods
previously approved for the 2013-2014 survey, with different
instruments being administered to providers and clinic administrators.
Minor changes to survey content will be made to eliminate unnecessary
questions, add new questions of interest, and improve formatting,
usability, and data quality. OMB approval is requested for one year.
The estimated burden per response for providers is 15 minutes and has
not changed since the previous OMB approval. The estimated burden per
response for administrators will be reduced from 40 minutes to 35
minutes. The total burden for participants is estimated at 1,916 hours.
Participation is voluntary and there are no costs to respondents other
than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Office-based physicians 2018-2019 Survey 1,000 1 15/60 250
(private sector). of Health Care
Providers about
Family Planning
Attitudes and
Practices.
Title X clinic providers 2018-2019 Survey 1,000 1 15/60 250
(public sector). of Health Care
Providers about
Family Planning
Attitudes and
Practices.
Non-Title X publicly funded 2018-2019 Survey 1,000 1 15/60 250
clinic providers (public of Health Care
sector). Providers about
Family Planning
Attitudes and
Practices.
Title X clinic administrators 2018-2019 Survey 1,000 1 35/60 583
(public sector). of
Administrators
of Health
Centers that
Provide Family
Planning.
Non-Title X publicly funded 2018-2019 Survey 1,000 1 35/60 583
clinic administrators (public of
sector). Administrators
of Health
Centers that
Provide Family
Planning.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,916
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of
Scientific Integrity, Office of the Associate Director for Science,
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-12373 Filed 6-7-18; 8:45 am]
BILLING CODE 4163-18-P